An International Collaborative Study Establishing a Reference Preparation for Antithrombin III

Summary

An international collaborative study involving 12 laboratories in 7 countries was carried out to establish a suitable reference preparation of antithrombin III (At III). The amount of At III present in two purified preparations, a freeze-dried normal plasma and local normal plasma pools was measured by clotting, immunological, and amidolytic assays. 120 assays were submitted of which 105 were accepted as valid for inclusion in subsequent analyses. Less laboratory to laboratory variation was found when At III was assayed in freeze-dried normal plasma, as compared to purified preparations of At III, and there was also less method to method variation when At III was measured in freeze-dried plasma. When measured as heparin co-factor activity, the two purified preparations contained only about half the level of At III found by immunoassay or progressive At III clotting assays. In contrast, the use of freeze-dried plasma provided results which showed excellent agreement between the various laboratories by all assays; accordingly, this material has been established by the World Health Organization as the International Reference Preparation for At III, with an assigned potency of 0.9 i. u. per ml.

Keywords

Antithrombin III-Standard-Assay methods - Collaborative study

• References

• 1 Nilsson IM. Report of the task force on standards of inhibitors of blood coagulation and fibrinolysis. Thromb Haemostas. 1976; 35: 475-476
• 2 Abildgaard U, Gravem K, Godal HC. Assay of progressive anti-thrombin in plasma. Thromb et Diath Haemorr. 1970; 24: 224-229
• 3 Howie PW, Prentice CR M, McNicol GP. A method of antithrombin estimation using plasmin defibrinated with ancrod. Br J Haematol. 1973; 25: 101-110
• 4 Biggs R, Denson KW E, Akman N, Barrett R, Hadden M. Antithrombin III, antifactor Xa and heparin. Br J Haematol. 1970; 19: 283-305
• 5 Bick RL, Kovacs I, Fekete LF. A new two-stage functional assay for antithrombin III (heparin co-factor). Clinical and laboratory evaluation. Thromb Res. 1976; 8: 745-746
• 6 Karges HE, Heimburger N, Loechelt C. A method for the quantitative determination of the antithrombin III (At III) activity in plasma and serum using the complex formation with heparin. Thromb et Diath Haemorr. 1975; 34: 347
• 7 Ødegard OR, Lie M, Abildgaard U. Heparin co-factor activity measured with an amidolytic method. Thromb Res. 1975; 6: 287-294
• 8 Abildgaard U, Lie M, Ødegard OR. Antithrombin (heparin co-factor) assay with ›new‹ chromogenic substrates (S-2278 and Chromozym-TH). Thromb Res. 1977; 11: 549-553
• 9 Gitel JN, Wessler S. Plasma At III: A quantitative assay of biological activity. Thromb Res. 1975; 7: 5-16
• 10 Yin ET, Eisenkramer L, Butler JV. Heparin interaction with activated factor X and its inhibitor. In: Heparin: Structure, Function and Clinical Implications . Ed. Bradshaw and Wessler Advances in Experimental Medicine and Biology: 1975. 52: 239-242
• 11 Ødegard OR, Lie M, Abilgaard U. Antifactor Xa activity measured with an amidolytic method. Haemostasis. 1975; 5: 265-275
• 12 Finney DJ. Statistical Method in Biological Assay . 1978. 3rd ed. Griffin & Co., London:
• 13 Kirkwood TB L. Predicting the stability of biological standards and products. Biometrics. 1977; 33: 736-742
• 14 Abildgaard U. Purification of two progressive antithrombins of human plasma. Scan J Lab Invest. 1967; 19: 190-195
• 15 Lane JL, Bird P, Rizza CR. A new assay for the measurement of total progressive antithrombin. Br J Haematol. 1975; 30: 103-115
• 16 Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin heparin co-factor. J Biol Chem. 1973; 248: 6490-6505
• 17 Barrowcliffe TW. Studies of heparin binding to antithrombin III by crossed Immunoelectrophoresis. Thromb Haemostas. 1979 in press
• 18 Ødegard OR, Abilgaard U. Antithrombin III: critical review of assay methods. Significance of variations in health and disease. Haemostasis. 1978; 7: 127-134
• 19 Marciniak E, Tsukamura S. Two progressive inhibitors of Factor Xa in human blood. Br J Haematol. 1972; 22: 341-351